Latest news with #Wienerberger
Yahoo
20-03-2025
- Business
- Yahoo
3 European Stocks That May Be Undervalued By As Much As 39.6%
As European markets grapple with concerns over U.S. trade tariffs and monetary policy uncertainties, the pan-European STOXX Europe 600 Index has recently experienced a decline, reflecting broader economic apprehensions. In such an environment, identifying undervalued stocks can be crucial for investors seeking opportunities; these stocks often exhibit strong fundamentals or potential for growth that may not yet be fully recognized by the market. Name Current Price Fair Value (Est) Discount (Est) Telefonaktiebolaget LM Ericsson (OM:ERIC B) SEK83.02 SEK164.54 49.5% Wienerberger (WBAG:WIE) €35.24 €69.57 49.3% CTT Systems (OM:CTT) SEK228.00 SEK443.67 48.6% Net Insight (OM:NETI B) SEK4.92 SEK9.58 48.6% Storytel (OM:STORY B) SEK90.85 SEK180.37 49.6% Star7 (BIT:STAR7) €6.30 €12.42 49.3% InTiCa Systems (XTRA:IS7) €4.22 €8.25 48.9% Fodelia Oyj (HLSE:FODELIA) €7.12 €13.91 48.8% MilDef Group (OM:MILDEF) SEK208.50 SEK405.57 48.6% Galderma Group (SWX:GALD) CHF96.38 CHF189.25 49.1% Click here to see the full list of 208 stocks from our Undervalued European Stocks Based On Cash Flows screener. Let's take a closer look at a couple of our picks from the screened companies. Overview: Borregaard ASA develops, produces, and markets specialized biomaterials and biochemicals globally, with a market cap of NOK17.56 billion. Operations: The company's revenue segments consist of Bio Materials at NOK2.62 billion, Bio Solutions at NOK4.24 billion, and Fine Chemicals at NOK799 million. Estimated Discount To Fair Value: 39.6% Borregaard is trading at NOK176, significantly below its estimated fair value of NOK291.48, suggesting it may be undervalued based on cash flows. Analysts forecast earnings growth of 14.6% annually, outpacing the Norwegian market's 8%. Recent financials show Q4 sales increased to NOK1.74 billion from NOK1.61 billion year-over-year, though full-year net income slightly declined to NOK823 million from NOK870 million. The proposed dividend for 2024 is set at NOK4.25 per share. Our earnings growth report unveils the potential for significant increases in Borregaard's future results. Click here to discover the nuances of Borregaard with our detailed financial health report. Overview: AddLife AB (publ) and its subsidiaries supply equipment, consumables, and reagents to the healthcare sector, research institutions, educational entities, and the food and pharmaceutical industries with a market cap of SEK18.21 billion. Operations: The company's revenue is primarily derived from its Labtech segment, which generated SEK3.80 billion, and its Medtech segment, which contributed SEK6.50 billion. Estimated Discount To Fair Value: 32% AddLife, trading at SEK149.4, is valued below its estimated fair value of SEK219.82, highlighting potential undervaluation based on cash flows. Analysts project significant earnings growth of 30.22% annually over the next three years, surpassing the Swedish market's average. Recent results show Q4 sales increased to SEK2.82 billion from SEK2.54 billion year-over-year, with net income improving to SEK94 million from a loss previously reported; a dividend of SEK0.75 per share was proposed for 2024. Upon reviewing our latest growth report, AddLife's projected financial performance appears quite optimistic. Unlock comprehensive insights into our analysis of AddLife stock in this financial health report. Overview: Colt CZ Group SE, along with its subsidiaries, is involved in the production, purchase, and sale of firearms, ammunition products, and tactical accessories across various regions including the Czech Republic, Canada the United States Europe Africa Asia and other international markets; it has a market cap of CZK43.31 billion. Operations: The company's revenue primarily comes from its Firearms and Accessories segment, which generated CZK26.22 billion. Estimated Discount To Fair Value: 30.9% Colt CZ Group, trading at CZK767, is significantly undervalued based on discounted cash flow analysis, with an estimated fair value of CZK1110.53. Despite a decline in profit margins from last year and high debt relative to operating cash flow, earnings are forecast to grow 58.3% annually over the next three years—outpacing the Czech market's growth rate. However, shareholders faced substantial dilution recently and dividends remain unsustainably covered by earnings or free cash flows. Our comprehensive growth report raises the possibility that Colt CZ Group is poised for substantial financial growth. Click here and access our complete balance sheet health report to understand the dynamics of Colt CZ Group. Unlock our comprehensive list of 208 Undervalued European Stocks Based On Cash Flows by clicking here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include OB:BRG OM:ALIF B and SEP:CZG. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
27-02-2025
- Business
- Yahoo
Uncovering 3 Global Stocks That May Be Trading Below Estimated Value
As global markets grapple with geopolitical tensions, tariff concerns, and fluctuating consumer spending, investors are increasingly focused on identifying opportunities amid the volatility. In this environment, stocks that may be trading below their estimated value can offer potential for growth when selected carefully based on sound fundamentals and market resilience. Name Current Price Fair Value (Est) Discount (Est) Wienerberger (WBAG:WIE) €33.62 €67.13 49.9% Guangdong Fenghua Advanced Technology (Holding) (SZSE:000636) CN¥15.16 CN¥30.22 49.8% América Móvil. de (BMV:AMX B) MX$15.01 MX$29.74 49.5% CD Projekt (WSE:CDR) PLN222.90 PLN441.95 49.6% LITALICO (TSE:7366) ¥1084.00 ¥2150.86 49.6% Sung Kwang BendLtd (KOSDAQ:A014620) ₩28200.00 ₩55949.99 49.6% Nyab (OM:NYAB) SEK5.27 SEK10.42 49.4% Cint Group (OM:CINT) SEK6.67 SEK13.22 49.5% Medical Data Vision (TSE:3902) ¥419.00 ¥836.85 49.9% Bactiguard Holding (OM:BACTI B) SEK34.80 SEK68.97 49.5% Click here to see the full list of 505 stocks from our Undervalued Global Stocks Based On Cash Flows screener. Let's dive into some prime choices out of the screener. Overview: Ningbo Sanxing Medical Electric Co., Ltd. manufactures and sells power distribution and utilization systems both in China and internationally, with a market cap of CN¥37.10 billion. Operations: The company generates revenue through its manufacturing and sales of power distribution and utilization systems in both domestic and international markets. Estimated Discount To Fair Value: 47.9% Ningbo Sanxing Medical Electric Ltd. trades at CN¥27.19, significantly below its estimated fair value of CN¥52.24, suggesting it is undervalued based on cash flows. Its revenue is expected to grow at 21.9% annually, outpacing the Chinese market's 13.3%. Despite an unstable dividend track record and earnings growth forecasted slower than the market, analysts agree on a potential price increase of 48.9%, indicating strong relative value compared to peers and industry standards. Upon reviewing our latest growth report, Ningbo Sanxing Medical ElectricLtd's projected financial performance appears quite optimistic. Unlock comprehensive insights into our analysis of Ningbo Sanxing Medical ElectricLtd stock in this financial health report. Overview: Ningbo Orient Wires & Cables Co., Ltd. offers land and subsea cable solutions both in China and internationally, with a market capitalization of CN¥32.39 billion. Operations: Ningbo Orient Wires & Cables Co., Ltd. generates revenue through its provision of cable solutions for both terrestrial and underwater applications across domestic and global markets. Estimated Discount To Fair Value: 31.1% Ningbo Orient Wires & Cables Ltd. is trading at CN¥47.2, which is 31.1% below its estimated fair value of CN¥68.5, highlighting its undervaluation based on cash flows. Earnings are expected to grow significantly at 31.4% annually, surpassing the Chinese market's growth rate of 25.5%. Despite an unstable dividend history, analysts anticipate a price rise of 37.4%. The company recently completed a share buyback worth CN¥107.18 million, enhancing shareholder value. The growth report we've compiled suggests that Ningbo Orient Wires & CablesLtd's future prospects could be on the up. Navigate through the intricacies of Ningbo Orient Wires & CablesLtd with our comprehensive financial health report here. Overview: Shenzhen Dynanonic Co., Ltd specializes in the research, development, manufacture, and sale of materials for lithium-ion batteries in China, with a market cap of CN¥10.34 billion. Operations: The company generates revenue primarily through its research and development, production, and sales of Nano-Lithium Iron Phosphate, amounting to CN¥7.78 billion. Estimated Discount To Fair Value: 48.9% Shenzhen Dynanonic is trading at CN¥39.04, significantly below its estimated fair value of CN¥76.33, indicating substantial undervaluation based on cash flows. The company is expected to become profitable within three years with earnings forecasted to grow annually by over 100%. A strategic joint venture with ICL Group aims to enhance market presence in Europe through a new production facility for lithium iron phosphate cathode materials, potentially boosting future revenue streams. Our expertly prepared growth report on Shenzhen Dynanonic implies its future financial outlook may be stronger than recent results. Click here and access our complete balance sheet health report to understand the dynamics of Shenzhen Dynanonic. Click through to start exploring the rest of the 502 Undervalued Global Stocks Based On Cash Flows now. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:601567 SHSE:603606 and SZSE:300769. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
27-02-2025
- Business
- Yahoo
3 European Stocks Estimated To Be Trading At Discounts Of Up To 45.2%
As European markets navigate cautious optimism amid geopolitical developments and mixed economic indicators, investors are keenly observing undervalued opportunities in the region. Identifying stocks trading at significant discounts can offer potential value, especially when market conditions present a blend of challenges and prospects for growth. Name Current Price Fair Value (Est) Discount (Est) Vimi Fasteners (BIT:VIM) €0.995 €1.95 48.9% Wienerberger (WBAG:WIE) €33.62 €67.13 49.9% CD Projekt (WSE:CDR) PLN222.90 PLN441.95 49.6% Vestas Wind Systems (CPSE:VWS) DKK104.05 DKK205.07 49.3% Nyab (OM:NYAB) SEK5.27 SEK10.42 49.4% Cint Group (OM:CINT) SEK6.67 SEK13.22 49.5% Surgical Science Sweden (OM:SUS) SEK159.00 SEK310.42 48.8% Groupe Airwell Société anonyme (ENXTPA:ALAIR) €1.24 €2.42 48.7% Bactiguard Holding (OM:BACTI B) SEK34.80 SEK68.97 49.5% Facephi Biometria (BME:FACE) €2.07 €4.04 48.7% Click here to see the full list of 201 stocks from our Undervalued European Stocks Based On Cash Flows screener. Underneath we present a selection of stocks filtered out by our screen. Overview: CVC Capital Partners plc is a private equity and venture capital firm that focuses on middle market secondaries, infrastructure, credit, management buyouts, leveraged buyouts, growth equity, mature investments, recapitalizations, strip sales and spinouts with a market cap of €24.61 billion. Operations: CVC Capital Partners plc generates revenue through its focus on middle market secondaries, infrastructure and credit investments, management and leveraged buyouts, growth equity, mature investments, recapitalizations, strip sales and spinouts. Estimated Discount To Fair Value: 11.6% CVC Capital Partners is trading at €23.15, slightly below its estimated fair value of €26.2, representing an 11.6% discount. Despite carrying a high level of debt, CVC's earnings are forecast to grow significantly at 27.4% annually over the next three years, outpacing the Dutch market's growth rate of 12.6%. Recent M&A activity includes interest in Akzo Nobel's South Asia portfolio and divesting a stake in HealthCare Global Enterprises to KKR & Co., potentially impacting future cash flows positively. The analysis detailed in our CVC Capital Partners growth report hints at robust future financial performance. Click to explore a detailed breakdown of our findings in CVC Capital Partners' balance sheet health report. Overview: Just Eat N.V. operates as a global online food delivery company with a market cap of approximately €3.92 billion. Operations: The company's revenue segments include North America (€1.97 billion), UK and Ireland (€1.39 billion), Northern Europe (€1.37 billion), and Southern Europe & Australia (€372 million). Estimated Discount To Fair Value: 45.2% Just Eat is trading at €19.37, significantly below its estimated fair value of €35.36, indicating it is undervalued based on cash flows. Despite a net loss of €1.64 billion in 2024, the company is expected to become profitable within three years with earnings growth forecasted at over 105% annually. The recent acquisition proposal by Prosus for approximately €4.1 billion underscores potential long-term value under private ownership and strategic realignment post-delistings. Our earnings growth report unveils the potential for significant increases in Just Eat future results. Click here and access our complete balance sheet health report to understand the dynamics of Just Eat Overview: Icade is a full-service real estate company operating throughout France, specializing in commercial property investment with a portfolio worth €6.8 billion and property development generating €1.3 billion in economic revenue for 2023, with a market capitalization of approximately €1.69 billion. Operations: The company's revenue segments include €1.21 billion from the Property Development Business and €375.60 million from Commercial Property Investment for 2023. Estimated Discount To Fair Value: 17.7% Icade is trading at €22.24, below its estimated fair value of €27.02, suggesting undervaluation based on cash flows. Despite a net loss of €275.9 million in 2024, the company is expected to achieve profitability within three years with earnings growth forecasted at 83% annually. Revenue growth is anticipated to outpace the French market, yet its high dividend yield remains unsustainable due to insufficient coverage by earnings or free cash flows. Our comprehensive growth report raises the possibility that Icade is poised for substantial financial growth. Take a closer look at Icade's balance sheet health here in our report. Unlock our comprehensive list of 201 Undervalued European Stocks Based On Cash Flows by clicking here. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTAM:CVC ENXTAM:TKWY and ENXTPA:ICAD. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
